Answers are grounded in this paper and cite their sources.
. Some triterpenoids have been approved for clinical use for the treatment of cancer, while other potent compounds are currently being evaluated in clinical trials. In this work, we provide a comprehensive overview of the types, structures, and cytotoxicity of plant-derived triterpenoids reported from 2015 to 2024. We also propose constructive strategies for their structural modifications based on their structure-activity relationships (SARs) in the hope of developing new anticancer drugs.
No takes yet. Share an insight, caveat, or question.
Olatunde et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: